These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12668150)

  • 1. Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function.
    Robinson S; Freeman P; Moore C; Touchon JC; Krentz L; Meshul CK
    Exp Neurol; 2003 Mar; 180(1):74-87. PubMed ID: 12668150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
    Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.
    Meshul CK; Kamel D; Moore C; Kay TS; Krentz L
    Exp Neurol; 2002 May; 175(1):257-74. PubMed ID: 12009777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes in extracellular glutamate in the rat dorsolateral striatum following a single cocaine injection.
    McKee BL; Meshul CK
    Neuroscience; 2005; 133(2):605-13. PubMed ID: 15878803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion.
    Meshul CK; Emre N; Nakamura CM; Allen C; Donohue MK; Buckman JF
    Neuroscience; 1999 Jan; 88(1):1-16. PubMed ID: 10051185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
    Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
    Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease.
    Ferguson MC; Nayyar T; Ansah TA
    Neurochem Int; 2014 May; 71():36-46. PubMed ID: 24704796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High and low responders to novelty show differential effects in striatal glutamate.
    Shakil SS; Holmer HK; Moore C; Abernathy AT; Jakowec MW; Petzinger GM; Meshul CK
    Synapse; 2005 Dec; 58(3):200-7. PubMed ID: 16138315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.
    Pérez-Otaño I; Oset C; Luquin MR; Herrero MT; Obeso JA; Del Río J
    Neurosci Lett; 1994 Jul; 175(1-2):121-5. PubMed ID: 7970192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease.
    Al-Sweidi S; Morissette M; Di Paolo T
    J Steroid Biochem Mol Biol; 2016 Jul; 161():84-91. PubMed ID: 26873133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease.
    Kuroiwa H; Yokoyama H; Kimoto H; Kato H; Araki T
    Metab Brain Dis; 2010 Jun; 25(2):177-83. PubMed ID: 20431930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
    Alam G; Edler M; Burchfield S; Richardson JR
    Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses.
    Meshul CK; Bunker GL; Mason JN; Allen C; Janowsky A
    J Neurochem; 1996 Nov; 67(5):1965-73. PubMed ID: 8863502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
    Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
    BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
    Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.
    Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu I; Nagatsu T
    Neurosci Lett; 1987 Sep; 80(2):213-8. PubMed ID: 2891089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.